0001209191-19-011504.txt : 20190220 0001209191-19-011504.hdr.sgml : 20190220 20190220161001 ACCESSION NUMBER: 0001209191-19-011504 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190215 FILED AS OF DATE: 20190220 DATE AS OF CHANGE: 20190220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YEAMAN KEVIN J CENTRAL INDEX KEY: 0001200469 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32431 FILM NUMBER: 19618339 MAIL ADDRESS: STREET 1: C/O DOLBY LABORATORIES, INC. STREET 2: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dolby Laboratories, Inc. CENTRAL INDEX KEY: 0001308547 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 900199783 STATE OF INCORPORATION: DE FISCAL YEAR END: 0924 BUSINESS ADDRESS: STREET 1: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: 415 558 0200 MAIL ADDRESS: STREET 1: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-15 0 0001308547 Dolby Laboratories, Inc. DLB 0001200469 YEAMAN KEVIN J C/O DOLBY LABORATORIES, INC. 1275 MARKET STREET SAN FRANCISCO CA 94103 1 1 0 0 President and CEO Class A Common Stock 2019-02-15 4 M 0 25000 30.49 A 57895 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Class A Common Stock 2019-02-15 4 S 0 25000 65.00 D 32895 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Class A Common Stock 109664 D Employee Stock Option (right to buy) 30.49 2019-02-15 4 M 0 25000 0.00 D 2022-12-21 Class A Common Stock 25000 206968 I By the Kevin and Rachel Yeaman Family Trust, dated May 14, 2009 Shares held following the reported transactions include 109,664 restricted stock units, which are subject to forfeiture until they vest. This option was granted for a total of 234,400 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 21, 2012, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. **All of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.** /s/ Daniel Rodriguez, Attorney-in-Fact for Kevin Yeaman 2019-02-20